Pharmacophore- and QSAR-guided discovery of natural product inhibitors targeting dehydrosqualene synthase in Staphylococcus aureus. [PDF]
Amorim J +5 more
europepmc +1 more source
Discovery of potent and highly selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for treating diabetic nephropathy. [PDF]
Ni H +5 more
europepmc +1 more source
Integrated computational-based design of putative dual TrkA/TrkB agonists for Alzheimer's disease: pharmacophore modelling, docking, MM/GBSA, DFT and dynamics studies. [PDF]
Vignesh Pandi A +7 more
europepmc +1 more source
Structure-Based Discovery of Glyoxalase-I Inhibitors: Evaluating the Role of Active Site Water Molecules. [PDF]
Anaam R, Isawi IH, Al-Balas Q.
europepmc +1 more source
Exploring potential VEGF receptor 2 inhibitors: a molecular modeling and pharmacophore-based screening approach. [PDF]
Mozzicafreddo M +6 more
europepmc +1 more source
In-silico identification and optimization of MMP-9 inhibitors for cerebral ischemia using structure based virtual screening, MD simulation, and binding free energy calculations. [PDF]
Zhang J, Zhang B, Feng H, Sheng C.
europepmc +1 more source
A Multistep Computational Approach to Achieve a Complete Human 5-Lipoxygenase Structure and Provide a Pharmacophore Model for Further Drug Design. [PDF]
Lombardo L +3 more
europepmc +1 more source
Pharmacophore-driven kinase profiling applied to the PKIS2 chemogenomic dataset. [PDF]
Bureau R +3 more
europepmc +1 more source
HIT101308137 and HIT104293658 nominate dual target chemotypes for PTPN1 and PTPN2 with preliminary selectivity in colorectal cancer cells. [PDF]
Huang C, Chen J, Chen R, Cao L.
europepmc +1 more source
Integrating AI in Medicinal Chemistry for Accelerated Drug Discovery: A Comprehensive SAR (CSAR) Optimization Strategy and Discovery of Potent ALDH3A1 Inhibitors. [PDF]
Jain S +15 more
europepmc +1 more source

